Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: An integrated prognosis model of pharmacogenomic gene signature and clinical information for diffuse large B-cell lymphoma patients following CHOP-like chemotherapy

Fig. 3

Integrated model performance for OS in ABC and GCB molecular subtypes. Kaplan–Meier curves with hazard ratio (HR), 95% confidence interval (CI) and log-rank p value for overall survival in the training cohort (a, b) and validating dataset (d, e) stratified by integrated model for OS into high and low risk. The ROC curves of the integrated model for prediction of OS in molecular subtypes in training dataset (c) and validating dataset (f)

Back to article page